GF/B37/EDP07
Approved by the Board on: 17 November 2017
Decision on the Secretariat’s Recommendation on Funding from the 2017-2019 Allocation
1.1 Set forth below is the Secretariat’s recommendation to approve funding up to an amount of US$ 1,117,868,607 and € 108,755,207, this includes allocation funding as well as US$ 27,873,561 of catalytic investments for matching funds.
The Board:
- Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of Section IV to GF/B37/EDP07 (“Table 1”);
- Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
- Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP;
Notes
Table 1: Secretariat’s Funding Recommendation on Funding from the 2017-2019 Allocation (available in Related Documents)